心肌梗死后乳头肌断裂的外科治疗:一项多中心研究
基于CAUTION研究国际多中心注册数据库,纳入2001年至2019年因心肌梗死后乳头肌断裂接受手术的214例患者,平均年龄66.9岁(标准差10.5),院内死亡率为24.8%,研究期间未见明显改善。多因素分析显示术前慢性肾功能不全、心脏骤停和体外循环时间是院内死亡的独立危险因素,合并冠状动脉旁路移植是早期生存的独立预测因素。
要点
- 心肌梗死后乳头肌断裂手术院内死亡率为24.8%,研究期间未见明显改善。
- 术前慢性肾功能不全、心脏骤停和体外循环时间与院内死亡风险升高独立相关。
- 合并冠状动脉旁路移植是早期生存的独立预测因素,作者认为应尽可能同期完成。
核心结论
- 心肌梗死后乳头肌断裂的外科治疗院内死亡率高,且在研究期间未改善。
- 由于合并冠状动脉旁路移植带来生存获益,作者认为应尽可能施行该附加手术以改善结局。
研究设计与样本
- 国际多中心注册研究,检索CAUTION研究数据库中2001年至2019年因心肌梗死后乳头肌断裂接受手术的患者,共纳入214例,主要终点为院内死亡。
主要发现
- 患者平均年龄66.9岁(标准差10.5);后内侧乳头肌是最常见断裂部位(71.9%),完全断裂占67.3%。
- 二尖瓣置换占82.7%,122例(57%)同期行冠状动脉旁路移植;院内死亡率为24.8%。
- 时间趋势显示研究期间院内死亡率无明显改善。
- 多因素分析:术前慢性肾功能不全(OR 2.62,95%CI 1.07-6.45,P=0.036)、心脏骤停(OR 3.99,95%CI 1.02-15.61,P=0.046)、体外循环时间(OR 1.01,95%CI 1.00-1.02,P=0.04)与院内死亡风险升高独立相关;合并冠状动脉旁路移植为早期生存的独立预测因素(OR 0.38,95%CI 0.16-0.92,P=0.031)。
临床怎么用
- 作者认为,因合并冠状动脉旁路移植带来生存获益,应尽可能同期施行该附加手术以改善结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Papillary muscle rupture (PMR) is a rare but potentially fatal complication of acute myocardial infarction. The aim of this study was to analyse the patient characteristics and early outcomes of the surgical management of post-infarction PMR from an international multicentre registry. METHODS: Patients underwent surgery for post-infarction PMR between 2001 through 2019 were retrieved from database of the CAUTION study. The primary end point was in-hospital mortality. RESULTS: A total of 214 patients were included with a mean age of 66.9 (standard deviation: 10.5) years. The posteromedial papillary muscle was the most frequent rupture location (71.9%); the rupture was complete in 67.3% of patients. Mitral valve replacement was performed in 82.7% of cases. One hundred twenty-two patients (57%) had concomitant coronary artery bypass grafting. In-hospital mortality was 24.8%. Temporal trends revealed no apparent improvement in in-hospital mortality during the study period. Multivariable analysis showed that preoperative chronic kidney disfunction [odds ratio (OR): 2.62, 95% confidence interval (CI): 1.07-6.45, P = 0.036], cardiac arrest (OR: 3.99, 95% CI: 1.02-15.61, P = 0.046) and cardiopulmonary bypass duration (OR: 1.01, 95% CI: 1.00-1.02, P = 0.04) were independently associated with an increased risk of in-hospital death, whereas concomitant coronary artery bypass grafting was identified as an independent predictor of early survival (OR: 0.38, 95% CI: 0.16-0.92, P = 0.031). CONCLUSIONS: Surgical treatment for post-infarction PMR carries a high in-hospital mortality rate, which did not improve during the study period. Because concomitant coronary artery bypass grafting confers a survival benefit, this additional procedure should be performed, whenever possible, in an attempt to improve the outcome. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov: NCT03848429.
引用
- Massimi G, Ronco D, De Bonis M, et al. Surgical treatment for post-infarction papillary muscle rupture: a multicentre study. Eur J Cardiothorac Surg. 2022. PMID: 34718501. doi:10.1093/ejcts/ezab469
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。